FDMT
4D Molecular Therapeutics, Inc.Company with tickers: FDMT
CIK
1650648
CUSIP
35104E100
Shares Outstanding
52,276,254
13F Activity (30d)
109 filings
104 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2023-09-22 | Mehra Uneek |
See Remarks | Other | 0 |
| 2023-10-01 | Mehra Uneek |
See Remarks | Award | 229,634 |
| 2023-12-11 | Kirn David |
Director, Chief Executive Officer | Award | 590,000 |
| 2023-12-11 | Mehra Uneek |
See Remarks | Award | 75,000 |
| 2023-12-11 | Kamal Fariborz |
President & COO | Award | 260,000 |
| 2023-12-11 | Bizily Scott |
Chief Legal Officer | Award | 130,000 |
| 2023-12-11 | Kim Robert Young |
Chief Medical Officer | Award | 250,000 |
| 2023-12-15 | Kirn David |
Director, Chief Executive Officer | Sell | 28,632 |
| 2023-12-18 | Kirn David |
Director, Chief Executive Officer | Sell | 4,702 |
| 2024-01-04 | Kirn David |
Director, Chief Executive Officer | Sell | 40,732 |
| 2024-01-04 | VIKING GLOBAL INVESTORS LP |
10% Owner | Sell | 540,000 |
| 2024-01-05 | Kirn David |
Director, Chief Executive Officer | Sell | 28,104 |
| 2024-01-05 | Kirn David |
Director, Chief Executive Officer | Sell | 133 |
| 2024-01-23 | Kirn David |
Director, Chief Executive Officer | Sell | 5,696 |
| 2024-02-05 | Kim Robert Young |
Chief Medical Officer | Sell | 6,000 |
| 2024-02-05 | Kim Robert Young |
Chief Medical Officer | Convert | 6,000 |
| 2024-02-05 | Kim Robert Young |
Chief Medical Officer | Sell | 12,000 |
| 2024-02-05 | Kim Robert Young |
Chief Medical Officer | Sell | 552 |
| 2024-02-05 | Kim Robert Young |
Chief Medical Officer | Convert | 6,000 |
| 2024-02-05 | Kim Robert Young |
Chief Medical Officer | Convert | 12,000 |
| 2024-02-05 | Kim Robert Young |
Chief Medical Officer | Convert | 12,000 |
| 2024-02-05 | Kim Robert Young |
Chief Medical Officer | Convert | 6,000 |
| 2024-02-05 | Kim Robert Young |
Chief Medical Officer | Sell | 6,000 |
| 2024-02-05 | Kim Robert Young |
Chief Medical Officer | Convert | 6,000 |
| 2024-02-08 | Bizily Scott |
Chief Legal Officer | Sell | 1,332 |
| 2024-02-08 | Bizily Scott |
Chief Legal Officer | Convert | 2,916 |
| 2024-02-08 | Bizily Scott |
Chief Legal Officer | Convert | 1,996 |
| 2024-02-08 | Bizily Scott |
Chief Legal Officer | Sell | 2,916 |
| 2024-02-08 | Bizily Scott |
Chief Legal Officer | Convert | 1,996 |
| 2024-02-08 | Bizily Scott |
Chief Legal Officer | Sell | 1,996 |
| 2024-02-08 | Kirn David |
Director, Chief Executive Officer | Sell | 92,001 |
| 2024-02-08 | Bizily Scott |
Chief Legal Officer | Convert | 1,332 |
| 2024-02-08 | Bizily Scott |
Chief Legal Officer | Convert | 1,332 |
| 2024-02-08 | Bizily Scott |
Chief Legal Officer | Convert | 2,916 |
| 2024-02-16 | Bizily Scott |
Chief Legal Officer | Convert | 500 |
| 2024-02-16 | Bizily Scott |
Chief Legal Officer | Convert | 1,250 |
| 2024-02-16 | Bizily Scott |
Chief Legal Officer | Convert | 1,250 |
| 2024-02-16 | Bizily Scott |
Chief Legal Officer | Convert | 500 |
| 2024-02-16 | Bizily Scott |
Chief Legal Officer | Sell | 1,750 |
| 2024-02-27 | Bizily Scott |
Chief Legal Officer | Convert | 1,909 |
| 2024-02-27 | Bizily Scott |
Chief Legal Officer | Convert | 1,909 |
| 2024-02-27 | Bizily Scott |
Chief Legal Officer | Sell | 1,909 |
| 2024-03-18 | Bizily Scott |
Chief Legal Officer | Convert | 500 |
| 2024-03-18 | Bizily Scott |
Chief Legal Officer | Sell | 1,750 |
| 2024-03-18 | Bizily Scott |
Chief Legal Officer | Convert | 1,250 |
| 2024-03-18 | Bizily Scott |
Chief Legal Officer | Convert | 1,250 |
| 2024-03-18 | Bizily Scott |
Chief Legal Officer | Convert | 500 |
| 2024-03-27 | Bizily Scott |
Chief Legal Officer | Convert | 4,342 |
| 2024-03-27 | Bizily Scott |
Chief Legal Officer | Sell | 5,833 |
| 2024-03-27 | Bizily Scott |
Chief Legal Officer | Convert | 4,342 |
Showing 151–200 of 328 transactions